论文部分内容阅读
目的观察雾化吸入普米克令舒和肌肉注射干扰素辅助治疗婴幼儿毛细支气管炎临床效果。方法将我院2007年1月至2011年12月收治的92例毛细支气管炎患儿随机分为治疗组46例和对照组46例。两组根据病情需要常规给予氧疗、抗病毒、抗感染、止咳、平喘、镇静等治疗,治疗组在此基础上加用普米克令舒雾化吸入和干扰素肌肉注射,观察两组咳嗽消退、喘憋减轻、肺部啰音和三凹征消失时间(天数d)。结果治疗组咳嗽消退、喘憋减轻、肺部啰音及三凹征消失时间均较对照组减少,两组比较差异有统计学意义(P<0.05)。结论雾化吸入普米克令舒和肌肉注射干扰素联合治疗对毛细支气管炎有较好疗效。
Objective To observe the clinical effect of atomization inhalation of pulmicort and intramuscular injection of interferon in the treatment of infant bronchiolitis. Methods 92 cases of bronchiolitis admitted to our hospital from January 2007 to December 2011 were randomly divided into treatment group (46 cases) and control group (46 cases). The two groups were treated routinely with oxygen therapy, antivirus, anti-infective, cough-relieving, antiasthmatic and sedative treatment according to the needs of the patients. On the basis of this, the treatment group was given Pulmicort Respiratory Aerosol inhalation and interferon intramuscular injection, Dissipated, relieved wheeze, pulmonary rales and disappearance of three concave signs (days d). Results The treatment group cough subsided, relieved wheezing, pulmonary rales and disappearance of three concave sign were reduced compared with the control group, the difference between the two groups was statistically significant (P <0.05). Conclusions The combination of atomized inhalation of pulmicort and intramuscular injection of interferon has a good effect on bronchiolitis.